Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, ...

Binding and crosslinking experiments demonstrate that this protein is the receptor for a recently described interleukin 7 (IL-7)-like factor, thymic stromal lymphopoietin (TSLP). Binding of TSLP ...

Thymic stromal lymphopoietin (TSLP) is an interleukin-7-like cytokine that is associated with the pathology of atopic dermatitis and asthma. Although the role of this cytokine has been studied in ...

Thymic stromal lymphopoietin (TSLP) is an important target associated with autoimmune diseases, various allergic conditions, chronic inflammation, and cancer. To facilitate the development of drugs ...

Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for ...

The following is a summary of "Vascular Remodeling and TSLP/Angiogenin Overexpression in Severe Mixed Asthma," published in the February 2025 issue of the Respiratory Research by Bertolini et al.

CDX-622 inhibits SCF and TSLP-dependent inflammatory signatures in human skin -- Phase 1 study in healthy volunteers ongoing -HAMPTON, N.J., ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AIO-001 is a long-acting monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), a drug in the same class as AstraZeneca’s first-to-market Tezspire (tezepelumab), which was approved ...

The data demonstrate that CDX-622 neutralizes both SCF and TSLP, reducing tissue mast cells and inhibiting Type 2 inflammatory responses, supporting its potential to improve clinical activity over ...